Skip to content

PERNIX THERAPEUTICS HOLDINGS, INC.: 10-Q filed 2011-08-15

What PERNIX THERAPEUTICS HOLDINGS, INC. reported in its quarterly report filed 2011-08-15 (fiscal Q2 2011): 39 published measures, 104 facts as tagged in accession 0001354488-11-002846.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-15
Fiscal period
fiscal Q2 2011
Accession
0001354488-11-002846 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERNIX THERAPEUTICS HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-3049,427,543USD
At 2010-12-3146,033,532USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-3027,571,047USD
At 2010-12-3127,128,593USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-3021,856,496USD
At 2010-12-3118,904,939USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-3016,635,332USD
At 2010-12-318,260,059USD
At 2010-06-3011,426,355USD
At 2009-12-314,578,476USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,501,752USD91
2011-01-01 to 2011-06-302,476,926USD181
2010-04-01 to 2010-06-30166,844USD91
2010-01-01 to 2010-06-305,435,007USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-308,515,416USD181
2010-01-01 to 2010-06-304,725,760USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-30113,210USD181
2010-01-01 to 2010-06-308,969USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-140,266USD181
2010-01-01 to 2010-06-303,891,377USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-30123USD181
2010-01-01 to 2010-06-30-1,769,258USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-3015,972,743USD
At 2010-12-3113,495,817USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-04-01 to 2011-06-3022,698,593shares91
2011-01-01 to 2011-06-3022,675,621shares181
2010-04-01 to 2010-06-3024,557,691shares91
2010-01-01 to 2010-06-3023,183,645shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-04-01 to 2011-06-3023,043,014shares91
2011-01-01 to 2011-06-3023,015,064shares181
2010-04-01 to 2010-06-3024,608,114shares91
2010-01-01 to 2010-06-3023,206,749shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-04-01 to 2011-06-300.07USD/shares91
2011-01-01 to 2011-06-300.11USD/shares181
2010-04-01 to 2010-06-300.01USD/shares91
2010-01-01 to 2010-06-300.23USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-04-01 to 2011-06-300.07USD/shares91
2011-01-01 to 2011-06-300.11USD/shares181
2010-04-01 to 2010-06-300.01USD/shares91
2010-01-01 to 2010-06-300.23USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-04-01 to 2011-06-30855,000USD91
2011-01-01 to 2011-06-301,578,000USD181
2010-04-01 to 2010-06-30201,730USD91
2010-01-01 to 2010-06-30-816,373USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-301,284,389USD
At 2010-12-311,213,850USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-06-30514,897USD181
2010-01-01 to 2010-06-30126,838USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-302,419,239USD91
2011-01-01 to 2011-06-304,147,590USD181
2010-04-01 to 2010-06-30359,840USD91
2010-01-01 to 2010-06-304,610,615USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-3037,049,352USD
At 2010-12-3132,090,001USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-3019,718,047USD
At 2010-12-3119,253,593USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2010-01-01 to 2010-06-30-30,291USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-06-303,785,547USD
At 2010-12-314,145,734USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-04-01 to 2011-06-304,657,011USD91
2011-01-01 to 2011-06-309,513,595USD181
2010-04-01 to 2010-06-302,787,581USD91
2010-01-01 to 2010-06-305,878,118USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-30464,506USD91
2011-01-01 to 2011-06-30570,664USD181
2010-04-01 to 2010-06-30315,998USD91
2010-01-01 to 2010-06-30587,249USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3022,705,730shares
At 2010-12-3122,627,727shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-06-309,408,586USD
At 2010-12-318,934,735USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-06-3021,856,496USD
At 2010-12-3118,904,939USD
At 2009-12-315,376,208USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-06-30264,967USD
At 2010-12-31264,967USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-06-302,341,144USD
At 2010-12-312,167,525USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,501,752USD91
2011-01-01 to 2011-06-302,476,926USD181
2010-01-01 to 2010-12-319,308,787USD365
2010-04-01 to 2010-06-30163,181USD91
2010-01-01 to 2010-06-305,435,007USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-06-3042,671USD181
2010-01-01 to 2010-06-3027,752USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-62,487USD91
2011-01-01 to 2011-06-30-92,664USD181
2010-04-01 to 2010-06-305,071USD91
2010-01-01 to 2010-06-308,019USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-1,648,000USD181
2010-01-01 to 2010-06-30-2,422,000USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2011-01-01 to 2011-06-3097,996USD181
2010-01-01 to 2010-06-302,480USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2011-01-01 to 2011-06-303,857,484USD181
2010-01-01 to 2010-06-302,646,581USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-3060,290USD181
2010-01-01 to 2010-06-3077,600USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-303,678,520USD181
2010-01-01 to 2010-06-30194,209USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30360,187USD181
2010-01-01 to 2010-06-30415,919USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-468,825USD181
2010-01-01 to 2010-06-301,869,228USD181

Inspect the source

Entity
PERNIX THERAPEUTICS HOLDINGS, INC. / CIK 0001024126
Captured
SEC response SHA-256
ea5702e7f2493df62521df0dc3f64facdf3d1dfc364324cd092f94bae2615a7e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001024126.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))